| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $115.0M | -38.1% |
| Cost of Revenue | $66.8M | -37.2% |
| Gross Profit | $48.2M | -39.3% |
| R&D Expense | $42.5M | +63.3% |
| SG&A Expense | $47.7M | +3.2% |
| Operating Income | -$72.0M | -154.8% |
| Pre-tax Income | -$64.6M | -303.6% |
| Income Tax | $1.8M | +0.1% |
| Net Income | -$68.7M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $199.3M | -25.6% |
| Accounts Receivable | $22.2M | -6.8% |
| Inventory | $31.1M | -9.2% |
| Current Assets | $261.9M | -21.4% |
| Total Assets | $403.2M | -15.9% |
| Current Liabilities | $39.8M | +18.9% |
| Total Liabilities | $62.3M | -10.1% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$49.0M | -279.1% |
| Capital Expenditures | $4.2M | +10.5% |
| Investing Cash Flow | -$6.8M | +82.6% |
| Financing Cash Flow | -$16.9M | -305.7% |
| Free Cash Flow | -$53.2M | -325.7% |
| -252.5% |
| EPS (Basic) | -$0.94 | -261.5% |
| EPS (Diluted) | -$0.94 | -261.5% |
| Stockholders' Equity |
| $340.8M |
| -16.9% |